ContraFect Corporation Prices Approximately $10 Million Public Offering of Common Stock and Concurrent $3 Million Private Placement of Common Stock to Pfizer

Ads

You May Also Like

Resverlogix Announces Participation in Upcoming Conferences

CALGARY, Alberta, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") ...

Inovio Pharmaceuticals to Present at Biotech Showcase

PLYMOUTH MEETING, Pa., Jan. 05, 2016 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today ...

Surgery Partners, Inc. Announces Third Quarter 2015 Results

NASHVILLE, Tenn., Nov. 12, 2015 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (or the "Company"), ...